Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Quidel

Quidel's Return On Capital Employed Insights

According to Benzinga Pro, during Q1, Quidel (NASDAQ:QDEL) earned $479.94 million, a 64.75% increase from the preceding quarter. Quidel also posted a total of $1.00 billion in sales, a 57.33% increase since Q4.

Benzinga · May 18, 2022

Quidel Clocks More Than Three-Fold Jump In COVID-19 Products

Quidel Corp's (NASDAQ:QDEL) Q1 sales more than doubled to $1 billion, beating the consensus of $890 million and meeting management expectations. The company attributed the increase to significantly increased sales of rapid immunoassay products, specifically QuickVue At-Home OTC COVID-19 tests, Sofia Influenza + SARS, and Sofia Influenza tests. "Our diverse suite of assays,…

Benzinga · May 5, 2022

Recap: Quidel Q1 Earnings

Quidel (NASDAQ:QDEL) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Earnings Quidel beat estimated earnings by 17.9%, reporting an EPS of $11.66 versus an estimate of $9.89.

Benzinga · May 4, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

The Daily Biotech Pulse: Evotec Earns $16M Milestone Payment, Genmab Hit With Adverse Tribunal Ruling, Quidel Announces Above-Consensus Q1 Revenues And More

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga · Apr 8, 2022

Quidel Expects Q1 Revenues To More Than Double On Higher COVID-19 Test Sales

Quidel Corp (NASDAQ: QDEL)

Benzinga · Apr 8, 2022

3 Low-Beta Stocks to Protect Your Portfolio from Market Volatility

Multi-decade high inflation, Ukraine-Russia hostilities, and forthcoming interest rate increases by the Fed are fueling serious stock market volatility. To avoid the wild price swings, we think investors could consider adding low-beta stocks ResMed (RMD), AMN Healthcare Services (AMN), and Quidel (QDEL) to their watchlists. Let’s discuss.

StockNews.com · Mar 4, 2022

Quidel's Q4 Earnings Beat Street View Despite 21% Decline In Sales

Quidel Corp's (NASDAQ: QDEL)

Benzinga · Feb 18, 2022

Read news from The Economist, FT, and more,
with one subscription

Quidel: Q4 Earnings Insights

Quidel (NASDAQ:QDEL) reported its Q4 earnings results on Thursday, February 17, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Earnings Quidel beat estimated earnings by 29.95%, reporting an EPS of $7.29 versus an estimate of $5.61.

Benzinga · Feb 17, 2022

Is Quidel Stock a Buy Under $100?

The shares of medical diagnostics company Quidel Corporation (QDEL) have lost momentum over the past few months. While the company witnessed strong demand for its rapid Covid antigen testing amid surging coronavirus cases, given its poor growth prospects and an ongoing investigation of its recent acquisition, can its shares recover…

StockNews.com · Feb 16, 2022

Coverage From

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.